Qual é o preço para AzurRx BioPharma, Inc. (AZRX)

O preço para AzurRx BioPharma, Inc. (AZRX) é $3.45

Qual é a capitalização de mercado para AzurRx BioPharma, Inc. (AZRX)

A capitalização de mercado para AzurRx BioPharma, Inc. (AZRX) é $4.29M

Histórico de Preços de AzurRx BioPharma, Inc. (AZRX)

AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).

Ano	Desempenho
2021	-37.15%
2020	-9.98%
2019	-42.81%
2018	-49.10%
2017	-28.62%
2016	0.00%

Ano

Desempenho

2021

-37.15%

2020

-9.98%

2019

-42.81%

2018

-49.10%

2017

-28.62%

2016

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$505.24	28.63%	US
Argenx SE ARGX.US	$846.09	29.41%	NL
Lonza Group AG LONN.SW	$731.69	6.47%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.75%	BE

Empresa

Preço da ação

Variação 1a%

País